Christopher Hohmann
Overview
Explore the profile of Christopher Hohmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
192
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schipper J, Sommer A, Nies R, Metze C, Meertens M, Wormann J, et al.
J Am Heart Assoc
. 2025 Feb;
14(3):e038834.
PMID: 39895535
Background: Mitral valve transcatheter edge-to-edge repair (M-TEER) has emerged as a viable therapy option in patients with severe mitral regurgitation and high surgical risk. Although atrial fibrillation is common among...
2.
von Stein P, von Stein J, Hohmann C, Wienemann H, Guthoff H, Korber M, et al.
JACC Cardiovasc Imaging
. 2024 Aug;
18(1):16-29.
PMID: 39207336
Background: Two subtypes of atrial functional mitral regurgitation (AFMR) have been described, one is characterized by Carpentier type I and the other by Carpentier type IIIb leaflet motion. Objectives: The...
3.
Wissmuller M, Wartner V, Hohmann C, Adler J, Kramer T, Hellmich M, et al.
Eur Respir J
. 2024 May;
63(5).
PMID: 38754949
No abstract available.
4.
Freilinger S, Kaemmerer H, Pittrow R, Achenbach S, Baldus S, Dewald O, et al.
BMC Cardiovasc Disord
. 2024 Mar;
24(1):181.
PMID: 38532336
Background: Adults with congenital heart defects (ACHD) globally constitute a notably medically underserved patient population. Despite therapeutic advancements, these individuals often confront substantial physical and psychosocial residua or sequelae, requiring...
5.
Kramer T, Nattmann P, Gerhardt F, Stafiej P, Dumitrescu D, Freyhaus H, et al.
ESC Heart Fail
. 2024 Jan;
11(3):1540-1552.
PMID: 38224960
Aims: In pulmonary arterial hypertension (PAH), upfront combination therapy with ERA and PDE5i is associated with a reduction in morbidity and mortality events and improves standard haemodynamics, but data remain...
6.
Ney S, Gertz R, Pennig L, Nies R, Holtick U, Volker L, et al.
J Clin Med
. 2024 Jan;
13(1).
PMID: 38202291
Background: Recently, a disease modifying therapy has become available for transthyretin amyloid cardiomyopathy (ATTR-CM). A validated monitoring concept of treatment is lacking, but a current expert consensus recommends three clinical...
7.
von Stein P, Seitz L, Wienemann H, Hohmann C, Baar T, Baldus S, et al.
Front Cardiovasc Med
. 2023 Dec;
10:1265452.
PMID: 38155989
Background: Previous trials investigating antithrombotic therapy with a direct oral anticoagulant (DOAC) and a P2Y12 inhibitor after percutaneous coronary intervention (PCI), termed dual therapy, allowed a short period of triple...
8.
Wissmuller M, Tichelbacker T, Finke K, Dohr J, Adler J, Ochs L, et al.
Dtsch Med Wochenschr
. 2023 Nov;
148(23):1498-1506.
PMID: 37949078
Patients with left heart disease (LHD) often display pulmonary hypertension (PH), which impacts morbidity and mortality. The pathophysiology of PH is complex and entails pulmonary congestion due to elevated left-sided...
9.
Hohmann C, Doulis A, Gietzen C, Adler C, Wienemann H, von Stein P, et al.
J Crit Care
. 2023 Nov;
79:154464.
PMID: 37948943
Purpose: Evaluate optic nerve sheath and pial diameters (ONSD, ONPD) via sonography and computed tomography (CT) after out-of-hospital cardiac arrest (CA) and to compare their prognostic significance with other imaging...
10.
Wissmuller M, Wartner V, Hohmann C, Adler J, Kramer T, Hellmich M, et al.
Eur Respir J
. 2023 Oct;
62(4).
PMID: 37827573
No abstract available.